Clinical Trial Update: Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing a regimen of insulin detemir plus insulin aspart versus insulin NPH plus regular human insulin in subjects with Type 1 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Humulin N (insulin isophane) (insulin isophane)
• Humulin R (human regular insulin) (regular human insulin)
• Levemir (insulin detemir) (insulin detemir)
• NovoLog (insulin aspart) (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED